Soleno Therapeutics Inc. (SLNO) stock rises during current market. Here’s to know why?
Soleno Therapeutics Inc. (NASDAQ: SLNO) stock gains by 42.65% in the current market, at last check. Soleno focuses on the research and marketing of new treatments for rare illnesses. DCCR Extended-Release pills, a once-daily oral tablet developed by the business, is now being tested in Phase 3 clinical research program for the treatment of Prader-Willi […]
What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?
In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. SLNO stock price ranged between $1.03 and $1.13. Due to recent developments, the SLNO stock could have better insight after the recent rally since there hasn’t been any pertinent news. Read […]
